Literature DB >> 19330565

Quantitative analysis of tumor growth rate and changes in tumor marker level: specific growth rate versus doubling time.

Esmaeil Mehrara1, Eva Forssell-Aronsson, Håkan Ahlman, Peter Bernhardt.   

Abstract

BACKGROUND: Doubling time (DT) of tumor volume has been widely used to estimate the growth rate of tumors. However, DT gives incorrect estimates of the average growth rate of tumors when the uncertainty of growth rate is considerable. Specific growth rate (SGR) is less affected by uncertainties and is a more relevant parameter. Optimized imaging techniques and prolonged interval between observations can reduce the uncertainty of growth rate estimation. DT is also used for defining changes in tumor marker level. The aim of this study was to compare DT and SGR as measures of growth rate when the uncertainty is negligible.
METHODS: Mathematical analysis and computer simulations were carried out assuming no uncertainty of growth rate estimation. Data from two previously published clinical studies were assessed by both variables.
RESULTS: Due to the non-linear relationship between DT and SGR, using these variables does not give similar results. The variation of DT is not uniformly indicating variations of the growth rate. DT largely overestimates the difference in growth rate of slowly growing tumors and underestimates the difference in growth rate of rapidly growing tumors. On the other hand, SGR uniformly indicates the difference between growth rates throughout all ranges. Quantitative analysis of clinical observations can lead to contradictory results depending on the variable used for growth rate.
CONCLUSION: The growth rate of tumor volume should be expressed by SGR, or percentage increase per unit time, regardless of the level of the uncertainty of growth rate estimation. This conclusion is also valid for changes in tumor marker level, whether it is correlated with the growth rate of tumor volume or not.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330565     DOI: 10.1080/02841860802616736

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  12 in total

1.  CA19-9-related tumor kinetics after first-line chemotherapy of patients with advanced pancreatic cancer: a monoinstitutional experience.

Authors:  Giuseppe Colloca; Antonella Venturino; Domenico Guarneri
Journal:  Med Oncol       Date:  2016-08-13       Impact factor: 3.064

2.  Clinical significance of pretreatment tumor growth rate for locally advanced non-small cell lung cancer.

Authors:  Benedict Osorio; Nikhil Yegya-Raman; Sinae Kim; Charles B Simone; Christina Theodorou Ross; Matthew P Deek; Dakim Gaines; Wei Zou; Liyong Lin; Jyoti Malhotra; Ke Nie; Joseph Aisner; Salma K Jabbour
Journal:  Ann Transl Med       Date:  2019-03

3.  Volumetric trends of progressive in-field recurrences after stereotactic radiosurgery of metastatic intracranial tumors.

Authors:  Purvee D Patel; Eric L Hargreaves; Adnan F Danish; Joseph Weiner; Shabbar F Danish
Journal:  J Radiosurg SBRT       Date:  2018

4.  A new method to estimate parameters of the growth model for metastatic tumours.

Authors:  Esmaeil Mehrara; Eva Forssell-Aronsson; Viktor Johanson; Lars Kölby; Ragnar Hultborn; Peter Bernhardt
Journal:  Theor Biol Med Model       Date:  2013-05-09       Impact factor: 2.432

5.  Objective assessment of tumour response to therapy based on tumour growth kinetics.

Authors:  E Mehrara; E Forssell-Aronsson; P Bernhardt
Journal:  Br J Cancer       Date:  2011-07-26       Impact factor: 7.640

6.  MDCT evaluation of the growth kinetics of serous and benign mucinous cystic neoplasms of the pancreas.

Authors:  Hamid Chalian; Hüseyin G Töre; Pedram Rezai; David J Bentrem; Vahid Yaghmai
Journal:  Cancer Imaging       Date:  2011-08-20       Impact factor: 3.909

7.  Mammary cancer initiation and progression studied with magnetic resonance imaging.

Authors:  Xiaobing Fan; Devkumar Mustafi; Erica Markiewicz; Marta Zamora; James Vosicky; Abby Leinroth; Jeffrey Mueller; Kay Macleod; Suzanne D Conzen; Gregory S Karczmar
Journal:  Breast Cancer Res       Date:  2014-12-16       Impact factor: 6.466

8.  Selection of Mesenchymal-Like Metastatic Cells in Primary Tumors - An in silico Investigation.

Authors:  Vipin Narang; Shek Yoon Wong; Shiang Rong Leong; Bindu Harish; Jean-Pierre Abastado; Alexandre Gouaillard
Journal:  Front Immunol       Date:  2012-04-27       Impact factor: 7.561

9.  In Vivo Tumor Growth Rate Measured by US in Preoperative Period and Long Term Disease Outcome in Breast Cancer Patients.

Authors:  Tae-Kyung Yoo; Jun Won Min; Min Kyoon Kim; Eunshin Lee; Jongjin Kim; Han-Byoel Lee; Young Joon Kang; Yun-Gyoung Kim; Hyeong-Gon Moon; Woo Kyung Moon; Nariya Cho; Dong-Young Noh; Wonshik Han
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

10.  Analysis of inter-patient variations in tumour growth rate.

Authors:  Esmaeil Mehrara; Eva Forssell-Aronsson
Journal:  Theor Biol Med Model       Date:  2014-05-20       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.